114
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Drug type and high risk behaviors associated with health-care utilization among people who inject drugs: a systematic review and meta-analysis

ORCID Icon, , , & ORCID Icon
Pages 1-9 | Received 13 Dec 2021, Accepted 29 Aug 2022, Published online: 06 Sep 2022

References

  • Al Wahaibi, N., Al Lawati, A., Al Ruqeishy, F., Al Khatri, A., Al-Farsi, Y., Juma, T. M., Al Hinai, F., Al-Sibani, N., Mahadevan, S., & Al-Adawi, S. (2019). The characteristics and patterns of utilization of healthcare services among Omanis with substance use disorders attending therapy for cessation. PloS one, 14(1), e0210532. https://doi.org/10.1371/journal.pone.0210532
  • Anguiano, M. C. C., Pérez, C. M., Aragón, A. B., Muñoz, J. S., & Küstner, B. M. (2020). Patterns of primary care among persons with schizophrenia: The role of patients, general practitioners and centre factors. International Journal of Mental Health Systems, 14(1), 82. https://doi.org/10.1186/s13033-020-00409-z
  • Armoon, B., Higgs, P., & Mohammadi, R. (2021). Mental health status, health service utilization, drug use behaviors associated with non-fatal overdose among people who use illicit drugs: A meta-analysis. Journal of Substance Use, 1–12. https://doi.org/10.1080/14659891.2021.2019331
  • Artenie, A. A., Jutras‐Aswad, D., Roy, É., Zang, G., Bamvita, J. M., Lévesque, A., & Bruneau, J. (2015). Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: Room for improvement. Journal of Viral Hepatitis, 22(10), 792–799. https://doi.org/10.1111/jvh.12393
  • Baral, S., Sherman, S. G., Millson, P., & Beyrer, C. (2007). Vaccine immunogenicity in injecting drug users: A systematic review. Lancet Infectious Diseases, 7(10), 667–674. https://doi.org/10.1016/s1473-3099(07)70237-2
  • Bayani, A., Ghiasvand, H., Rezaei, O., Fattah Moghaddam, L., Noroozi, A., Ahounbar, E., Higgs, P., & Armoon, B. (2020). Factors associated with HIV testing among people who inject drugs: A meta-analysis. Journal of Addictive Diseases, 38(3), 361–374. https://doi.org/10.1080/10550887.2020.1771235
  • Bayat, A.-H., Mohammadi, R., Moradi-Joo, M., Bayani, A., Ahounbar, E., Higgs, P., Hemmat, M., Haghgoo, A., & Armoon, B. (2020). HIV and drug related stigma and risk-taking behaviors among people who inject drugs: A systematic review and meta-analysis. Journal of Addictive Diseases, 38(1), 71–83. https://doi.org/10.1080/10550887.2020.1718264
  • Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4), 1088–1101. https://doi.org/10.2307/2533446
  • Booth, R. E., Campbell, B. K., Mikulich-Gilbertson, S. K., Tillotson, C. J., Choi, D., Robinson, J., Calsyn, D. A., Mandler, R. N., Jenkins, L. M., Thompson, L. L., Dempsey, C. L., Liepman, M. R., & McCarty, D. (2011). Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS and Behavior, 15(1), 30–44. https://doi.org/10.1007/s10461-010-9751-7
  • Capoccia, V. A., Grazier, K. L., Toal, C., Ford, J. H., & Gustafson, D. H. (2012). Massachusetts’s experience suggests coverage alone is insufficient to increase addiction disorders treatment. Health Affairs, 31(5), 1000–1008. https://doi.org/10.1377/hlthaff.2011.0326
  • Chitwood, D. D., McBride, D. C., French, M. T., & Comerford, M. (1999). Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users, and nonusers. Substance Use & Misuse, 34(4–5), 727–746. https://doi.org/10.3109/10826089909037240
  • Cisneros, G. O., Douaihy, A. B., & Kirisci, L. (2009). Access to healthcare among injection drug users at a needle exchange program in Pittsburgh, PA. Journal of Addiction Medicine, 3(2), 89–94. https://doi.org/10.1097/ADM.0b013e318185e71d
  • Colledge, S., Larney, S., Bruno, R., Gibbs, D., Degenhardt, L., Yuen, W. S., Dietze, P., & Peacock, A. (2020). Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia. Drug and Alcohol Dependence, 216, 108267. https://doi.org/10.1016/j.drugalcdep.2020.108267
  • Darke, S., Ross, J., Teesson, M., & Lynskey, M. (2003). Health service utilization and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction, 98(8), 1129–1135. https://doi.org/10.1046/j.1360-0443.2003.00430.x
  • Digiusto, E., & Treloar, C. (2007). Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction, 102(6), 958–969. https://doi.org/10.1111/j.1360-0443.2007.01842.x
  • eCruz, C. C., Salom, C. L., Dietze, P., Lenton, S., Burns, L., & Alati, R. (2018). Frequent experience of discrimination among people who inject drugs: Links with health and wellbeing. Drug and Alcohol Dependence, 190, 188–194. https://doi.org/10.1016/j.drugalcdep.2018.06.009
  • eCruz, C. C., Salom, C., Parsell, C., Dietze, P., Burns, L., & Alati, R. (2020). Social domains of discrimination against people who inject drugs: Links with health and wellbeing. International Journal of Drug Policy, 77, 102620. https://doi.org/10.1016/j.drugpo.2019.102620
  • Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. Bmj, 315(7109), 629–634. https://doi.org/10.1136/bmj.315.7109.629
  • Flath, N., Tobin, K., Mihailovic, A., Hammond, P., & Latkin, C. (2018). Evaluating a dyadic intervention on risk reduction among people who inject drugs. Substance Abuse: Research and Treatment, 12, 1178221818799753. https://doi.org/10.1177/1178221818799753
  • French, M. T., McGeary, K. A., Chitwood, D. D., & McCoy, C. B. (2000). Chronic illicit drug use, health services utilization and the cost of medical care. Social Science & Medicine, 50(12), 1703–1713. https://doi.org/10.1016/s0277-9536(99)00411-6
  • Gray, M. E., Rogawski Mcquade, E. T., Scheld, W. M., & Dillingham, R. A. (2018). Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: A retrospective cohort study. BMC Infectious Diseases, 18(1), 532. https://doi.org/10.1186/s12879-018-3408-y
  • Heard, E., Smirnov, A., Massi, L., & Selvey, L. A. (2021). How can general practitioners support people who inject drugs to engage with direct-acting antiviral treatment for hepatitis C?: A qualitative study. Australian Journal of General Practice, 50(10), 716–721. https://doi.org/10.31128/AJGP-03-21-5899
  • Heinzerling, K. G., Kral, A. H., Flynn, N. M., Anderson, R., Scott, A., Gilbert, M., Asch, S. M., & Bluthenthal, R. N. (2006). Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence, 81(2), 167–178. https://doi.org/10.1016/j.drugalcdep.2005.06.008
  • Hope, V., Ncube, F., Parry, J., & Hickman, M. (2015). Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiology and Infection, 143(1), 120–131. https://doi.org/10.1017/S0950268814000284
  • Islam, M. M., Topp, L., Conigrave, K. M., & Day, C. A. (2013). Opioid substitution therapy clients’ preferences for targeted versus general primary health‐care outlets. Drug and Alcohol Review, 32(2), 211–214. https://doi.org/10.1111/j.1465-3362.2012.00498.x
  • Islam, M. M., Topp, L., Conigrave, K. M., White, A., Haber, P. S., & Day, C. A. (2013). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4), 326–332. https://doi.org/10.1016/j.drugpo.2012.06.002
  • Karimi, S. E., Bayani, A., Higgs, P., Bayat, A.-H., Hemmat, M., Ahounbar, E., Armoon, B., & Fakhri, Y. (2020). Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: A systematic review and Meta-analysis. Substance Abuse Treatment, Prevention, and Policy, 15(1), 64. https://doi.org/10.1186/s13011-020-00306-1
  • Kendall, C. E., Boucher, L. M., Donelle, J., Martin, A., Marshall, Z., Boyd, R., Oickle, P., Diliso, N., Pineau, D., & Renaud, B. (2020). Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Services Research, 20(1), 1–12. https://doi.org/10.1186/s12913-020-05670-z
  • Kendall, C. E., Boucher, L. M., Mark, A. E., Martin, A., Marshall, Z., Boyd, R., Oickle, P., Diliso, N., Pineau, D., Renaud, B., & Vu, T. M. T. (2017). A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada. Harm Reduction Journal, 14(1), 1–10. https://doi.org/10.1186/s12954-017-0143-4
  • Knowlton, A. R., Hoover, D. R., Chung, S.-E., Celentano, D. D., Vlahov, D., & Latkin, C. A. (2001). Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence, 64(1), 55–62. https://doi.org/10.1016/s0376-8716(00)00228-3
  • Lambdin, B. H., Bluthenthal, R. N., Zibbell, J. E., Wenger, L., Simpson, K., & Kral, A. H. (2019). Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. International Journal of Drug Policy, 74, 299–304. https://doi.org/10.1016/j.drugpo.2019.10.004
  • Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174. https://doi.org/10.2307/2529310
  • Marshall, A., Grebely, J., Dore, G., & Treloar, C. (2020). Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience. Drug and Alcohol Dependence, 206, 107705. https://doi.org/10.1016/j.drugalcdep.2019.107705
  • Mizuno, Y., Wilkinson, J. D., Santibanez, S., Dawson Rose, C., Knowlton, A., Handley, K., Gourevitch, M. N., & Team, I. (2006). Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care, 18(5), 417–425. https://doi.org/10.1080/09540120500162247
  • Mlunde, L. B., Sunguya, B. F., Mbwambo, J. K. K., Ubuguyu, O. S., Shibanuma, A., Yasuoka, J., & Jimba, M. (2016). Correlates of health care seeking behaviour among people who inject drugs in Dar es Salaam, Tanzania. International Journal of Drug Policy, 30, 66–73. https://doi.org/10.1016/j.drugpo.2015.12.012
  • Moradi-Joo, M., Ghiasvand, H., Noroozi, M., Armoon, B., Noroozi, A., Karimy, M., Rostami, A., Mirzaee, M. S., & Hemmat, M. (2019). Prevalence of skin and soft tissue infections and its related high-risk behaviors among people who inject drugs: A systematic review and meta-analysis. Journal of Substance Use, 24(4), 350–360. https://doi.org/10.1080/14659891.2019.1572805
  • Nambiar, D., Stoové, M., & Dietze, P. (2014). A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs. BMC Health Services Research, 14(1), 1–7. https://doi.org/10.1186/1472-6963-14-308
  • Noroozi, M., Armoon, B., Ghisvand, H., Noroozi, A., Karimy, M., Bazrafshan, M. R., Marshall, B. D., & Dieji, B. (2019). Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran. Journal of Cosmetic Dermatology, 18(1), 258–262. https://doi.org/10.1111/jocd.12675
  • Noroozi, A., Kebriaeezadeh, A., Mirrahimi, B., Armoon, B., Ahounbar, E., Narenjiha, H., Salehi, M., & Karamouzian, M. (2021). Opium tincture-assisted treatment for opioid use disorder: A systematic review. Journal of Substance Abuse Treatment, 129, 108519. https://doi.org/10.1016/j.jsat.2021.108519
  • Noroozi, M., Marshall, B. D., Noroozi, A., Armoon, B., Sharifi, H., Farhoudian, A., Ghiasvand, H., Vameghi, M., Rezaei, O., Sayadnasiri, M., & Pouya, R. H. (2018). Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach. Drug and Alcohol Review, 37(Suppl 1), S303–S308. https://doi.org/10.1111/dar.12646
  • Noroozi, M., Noroozi, A., Sharifi, H., Harouni, G. G., Marshall, B. D., Ghisvand, H., Qorbani, M., & Armoon, B. (2019). Needle and syringe programs and HIV-related risk behaviors among men who inject drugs: A multilevel analysis of two cities in Iran. International Journal of Behavioral Medicine, 26(1), 50–58. https://doi.org/10.1007/s12529-018-9758-4
  • Pourciau, T., Sanders, A. F., & Buckel, B. (1992). Changing trends in treatment of substance abuse: A look at some of the factors involved in third-party providers and treatment planning. Journal of the Louisiana State Medical Society, 144(7), 321–324. https://pubmed.ncbi.nlm.nih.gov/1331275/
  • Rezaei, O., Ghiasvand, H., Higgs, P., Noroozi, A., Noroozi, M., Rezaei, F., Armoon, B., & Bayani, A. (2020). Factors associated with injecting-related risk behaviors among people who inject drugs: A systematic review and meta-analysis study. Journal of Addictive Diseases, 38(4), 420–437. https://doi.org/10.1080/10550887.2020.1781346
  • Riley, E. D., Safaeian, M., Strathdee, S. A., Brooner, R. K., Beilenson, P., & Vlahov, D. (2002). Drug user treatment referrals and entry among participants of a needle exchange program. Substance Use & Misuse, 37(14), 1869–1886. https://doi.org/10.1081/JA-120014088
  • Riley, E. D., Wu, A. W., Junge, B., Marx, M., Strathdee, S. A., & Vlahov, D. (2002). Health services utilization by injection drug users participating in a needle exchange program. American Journal of Drug and Alcohol Abuse, 28(3), 497–511. https://doi.org/10.1081/ada-120006738
  • Roe, B., Beynon, C., Pickering, L., & Duffy, P. (2010). Experiences of drug use and ageing: Health, quality of life, relationship and service implications. Journal of Advanced Nursing, 66(9), 1968–1979. https://doi.org/10.1111/j.1365-2648.2010.05378.x
  • Rosenthal, E. S., Karchmer, A. W., Theisen-Toupal, J., Castillo, R. A., & Rowley, C. F. (2016). Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. American Journal of Medicine, 129(5), 481–485. https://doi.org/10.1016/j.amjmed.2015.09.024
  • Saitz, R., Horton, N. J., Larson, M. J., Winter, M., & Samet, J. H. (2005). Primary medical care and reductions in addiction severity: A prospective cohort study. Addiction, 100(1), 70–78. https://doi.org/10.1111/j.1360-0443.2005.00916.x
  • Sambamoorthi, U., Warner, L. A., Crystal, S., & Walkup, J. (2000). Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. Drug and Alcohol Dependence, 60(1), 77–89. https://doi.org/10.1016/s0376-8716(99)00142-8
  • Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605. https://doi.org/10.1007/s10654-010-9491-z
  • Stein, M. D., Phillips, K. T., Herman, D. S., Keosaian, J., Stewart, C., Anderson, B. J., Weinstein, Z., & Liebschutz, J. (2021). Skin‐cleaning among hospitalized people who inject drugs: A randomized controlled trial. Addiction, 116(5), 1122–1130. https://doi.org/10.1111/add.15236
  • Stopka, T. J., Hutcheson, M., & Donahue, A. (2017). Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: Qualitative findings from health navigators with the iDU (“I do”) Care Collaborative. Harm Reduction Journal, 14(1), 26. https://doi.org/10.1186/s12954-017-0151-4
  • Strathdee, S. A., Ricketts, E. P., Huettner, S., Cornelius, L., Bishai, D., Havens, J. R., Beilenson, P., Rapp, C., Lloyd, J. J., & Latkin, C. A. (2006). Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence, 83(3), 225–232. https://doi.org/10.1016/j.drugalcdep.2005.11.015
  • Yazdanian, M., Armoon, B., Noroozi, A., Mohammadi, R., Bayat, A.-H., Ahounbar, E., Higgs, P., Nasab, H. S., Bayani, A., & Hemmat, M. (2020). Dental caries and periodontal disease among people who use drugs: A systematic review and meta-analysis. BMC Oral Health, 20(1), 1–18. https://doi.org/10.1186/s12903-020-1010-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.